Company Overview

Early Signals. Better Health. 

Diabetes Testing Centers™ (DTC) exists to shift healthcare from reactive treatment to proactive prevention by making early detection of chronic disease simple, non-invasive, and practical for everyday clinical workflows. We help providers identify risk before irreversible damage occurs — so patients have a real chance to live longer, healthier lives and make it home safely each day.

Who We Are

DTC is a family-owned healthcare company founded by former family practice owners with more than 30 years of combined clinical and Fortune 5 healthcare leadership experience. Inspired by firsthand exposure to preventable complications—including diabetic amputations witnessed in practice—we built DTC on a simple belief: early detection is not optional; it is a responsibility.

Today, DTC serves as a healthcare consulting firm, management services organization (MSO), program licensor, and implementation partner helping medical groups, ACOs, FQHCs, health systems, and value-based care organizations integrate structured chronic-risk detection into everyday clinical workflows. Through our License & Partnership Models, organizations can deploy the DTC chronic-risk pathway—including TriageIQ™ and implementation support—under a scalable licensing framework.

Supported by a national network of more than 20,000 medical providers across the United States, DTC is committed to helping healthcare organizations identify risk earlier, improve patient outcomes, and strengthen coordinated, value-driven care.

What We Do

DTC equips providers with rapid, non-invasive chronic-risk pre-screening and structured triage routing designed to surface patient-reported risk signals during the same visit — without adding staff, requiring construction, or disrupting existing workflows.

Our focus is on areas where chronic disease often progresses silently, including neurological, cardiometabolic, behavioral, functional, vascular, sensory, and patient-support concerns.

At the center of this model is the TriageIQ™ family of pre-screeners, including Adult and Geriatric editions, with additional population-specific editions in development. TriageIQ™ helps capture structured, age-appropriate patient-reported risk signals before the visit begins and organize them for provider review — supporting decisions about focused screening, testing, follow-up, referral, or care-management consideration.

TriageIQ™ is the formalization of fifteen years of chronic risk assessment experience. Since 2010, DTC has implemented chronic disease risk assessments across a national network of independent practices. The patterns observed across that deployment history — which intake signals reliably route patients to which clinical pathways — are the clinical foundation TriageIQ™ was built to capture. The instrument is clinically grounded and evidence-informed. Item content has been reviewed for face validity, and a formal psychometric validation program is underway.

Use "is underway" only if a protocol exists. If not, use "is planned" — that sentence is a factual assertion a medical director may ask you to substantiate.

One thing the redaction does not solve

Stripping the citations does not conceal the composition. Those item sets are among the most recognizable in primary care; a competent competitor reading the patient pages identifies them on sight. The verbatim items are the disclosure — the citation is only the label on it.

The levers that actually protect composition, in order:

1. Don't ship provider pages with patient pages. Scoring, routing, and provenance go out under license/NDA only. This is the biggest gap and costs nothing to close.

2. Finish what you started in v5.1. You already replaced the pain and alcohol instruments with proprietary equivalents. Sections B and C are the last two third-party dependencies. Replacing them ends the question permanently and removes the verbatim-fidelity gate that's currently blocking your cut-point claims.

Domain count — your six reconciles cleanly

Mapping the v7.2 blocks against the site's six:

• Neurological ← A (cognitive)

• Behavioral health ← B, C, D — all three roll up coherently

• Population health ← Q1–Q3 · Pain/function ← Q4 · Cardiometabolic ← Q5 · Renal ← E

That's a defensible six. Only Q6 (prevention/screening) and S (remote supplement) sit outside it — S is a delivery-mode supplement rather than a domain, so Q6 is the only genuine orphan. Your master profile's "five" is the outdated figure; update that.

On cutting Q6 for time: it's the correct target — 60–90 seconds, and the pack-year item is your highest-friction question. But it's the block feeding preventive care-gap closure, which is your strongest VBC talking point with ACOs. Consider moving it to provider-completed or a separate care-gap sheet rather than deleting it. You keep the ACO story and get the time back.

How It Works

Every DTC engagement follows a three-step pathway:

• Pre-Screen — TriageIQ™ surfaces patient-reported risk signals and organizes them for provider review

• Test — Providers evaluate signals through the focused, non-invasive assessments and testing pathways they select

• Treat — Provider-directed care, supported by streamlined documentation and structured follow-up pathways

Clinics can launch in as little as 30 days, inside existing space and workflows — adding earlier detection without operational strain.

The Impact

Chronic disease rarely announces itself. Research consistently shows that earlier recognition of cognitive decline, neuropathy, vascular disease, and cardiometabolic risk creates the window in which intervention is most effective — before complications like amputation, stroke, and late-stage dementia become likely outcomes.

These are not abstractions. They are parents, grandparents, and patients who get to return home healthier, avoid preventable complications, and live with dignity.